MICHAEL FRUMOVITZ to Cancer Survivors
This is a "connection" page, showing publications MICHAEL FRUMOVITZ has written about Cancer Survivors.
Connection Strength
0.104
-
A phase III study of transdermal granisetron versus oral ondansetron for women with gynecologic cancers receiving pelvic chemoradiation. Support Care Cancer. 2021 Jan; 29(1):213-222.
Score: 0.104